Remove 2019 Remove Community Remove Individual Remove Insurance
article thumbnail

Episode 282: Anti-Racism in Medicine Series – Episode 20 – Medical Racism and Indigenous Peoples

The Clinical Problem Solvers

During this episode, we hear from Dr. Nav Persaud, a staff physician in the Department of Family and Community Medicine at St. The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon.

Medical 52
article thumbnail

District Court Interprets EKRA

FDA Law

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. EKRA is codified at 18 U.S.C. § 220 and was described on HP&M’s blog here. 18 U.S.C. § 24(b) (emphasis added). EKRA Issue.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

District Court Interprets EKRA

FDA Law

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. EKRA is codified at 18 U.S.C. § 220 and was described on HP&M’s blog here. 18 U.S.C. § 24(b) (emphasis added). EKRA Issue.

article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Psychedelics have been used by communities around the globe for hundreds of years (or more). And yet there are reasons for caution. Ethical issues , including colonization of psychedelics by big pharma.

article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

But back in 2019, there was a lot of disagreement in our group about whether for a patient with cancer and cancer related pain and a substance use disorder, whether palliative care was the appropriate specialty to care for those patients. For those individuals, how do you think about that? Pearls tips?